ОСОБЛИВОСТІ МОРФОМЕТРИЧНИХ ПОКАЗНИКІВ СЕРЦЯ У ГОСТРОМУ ПЕРІОДІ ГЕМОДИНАМІЧНОГО ІШЕМІЧНОГО ІНСУЛЬТУ
DOI:
https://doi.org/10.11603/2415-8798.2013.2.5750Abstract
В 56 хворих у гострому періоді гемодинамічного ішемічного інсульту на тлі супутньої артеріальної гіпертензії досліджено морфометричні показники серця. Патологічне ремоделювання лівого шлуночка (ЛШ) виявлено в 82,1 % хворих: у 35,7 % – ексцентричну гіпертрофію ЛШ, в 35,7 % – концентричну гіпертрофію ЛШ та у 10,7 % хворих – концентричне ремоделювання ЛШ. Переважав еукінетичний (48,2 %) та гіпокінетичний (41,2 %) типи центральної гемодинаміки.
References
Vylkenskhof Ursula. Spravochnyk po ékhokardyohrafyy / Ursula Vylkenskhof. – M. : Medytsynskaya lyteratura. – 2008. – 229 s.
Murashko N. K. Tserebralʹnyy hemodynamichnyy rezerv u khvorykh na arterialʹnu hipertenziyu / N. K. Murashko, Samaali Khishem // Liky Ukrayiny. – 2010. – № 1 (127). – S. 112–114.
Strutynskyy A. V. Ékhokardyohrafyya. Anamnez y ynterpretatsyya / A. V. Strutynskyy. – MEDpress-ynform. – 2001. – 204 s.
Talaeva T. V. Renyn-anhyotenzynovaya systema v kardyovaskulyarnoy patolohy: vozmozhnosty fakrmakolohycheskoy korrektsyy / T. V. Talaeva, V. V. Bratusʹ // Ukrayinsʹkyy medychnyy chasopys. – 2012. – № 1 (87). – S. 115–122.
Shyller M. Klinichna ekhokardiohrafiya / M. Shyller, M. A. Osypov. – M. : Myr, – 2005. – 242 s.
Cardiovascular morbidity and mortality in losartan interventional for endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol / Dahlof B., Devereux R., Kjeldsen S. [et al.] for the LIFE Study Group. // Lancet. – 2002. – Vol. 359. – P. 995–1003.
Clinical significance of left ventricular hypertrophy and changes in leftvenricular mass in high-risk hypertensive patients: a subanalysis of the Candesartan / S. Yasuno, K. Ueshima, K. Oba [et al.] Antihypertensive Survival Evaluation in Japan trial // J. Hypertension. – 2009. – Vol. 27. – P. 1706–1712.
Left ventricular hypertrophy increases cardiovascular risk independently of in- and out-of office blood pressure values / M. Bombelli, R. Facchetti, S. Carugo [et al.] // J. Hypertension. – 2009. – Vol. 27. – P. 2458–2464.
Michael A. Bauml Left ventricular hypertrophy: An overlooked cardiovascular risk factor / A. Michael // Cleveland Clinic Journal of Medicine. – 2010. – Vol. 77 6. – R. 381–387.
Devereux R. B. Prognostic significance of left ventricular mass change during treatment of hypertension / R. B. Devereux, E. Gerdts // JAMA. – 2004. – Vol. 292. – P. 2350–2356.
Relationship Between Left Ventricular Hypertrophy and 24-H Ambulatory Blood Pressure Monitoring in Patients After Acute Ischemic Stroke /Castilla Guerra, L. Fernandez Moreno, M. C. Alvarez Suero J. [et al.] // Journal of Hypertension. – 2010. – Vol. 28. – P. e89.
Silent cerebral matter lesions in middle-aged essential hypertensive patients / C. Sierra, A. Sierra, Mercader [et al.] // J. Hypertens. – 2002. – Vol. 20. – P. 519–524.
Downloads
Published
How to Cite
Issue
Section
License
Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
